When This Biopsy Is Recommended
This biopsy is typically recommended after a raised PSA result, an abnormal digital rectal exam, or a suspicious finding on a prior MRI, to confirm or rule out prostate cancer before any treatment decision is made.
How the Biopsy Targets the Right Area
An MRI is performed first to identify areas of the prostate that need closer evaluation. During the biopsy, this imaging is combined in real time with ultrasound, allowing the needle to be guided directly to the identified area rather than sampling the prostate more broadly.
Before, During & After the Biopsy
Before the biopsy, an MRI is reviewed to identify the specific area or areas of concern within the prostate.
During the procedure, the MRI images are fused with real-time ultrasound to guide biopsy needles directly to the identified area, typically performed under local anesthesia or light sedation.
After the biopsy, mild discomfort and minor bleeding in urine or semen are common for a short period, and results are usually available within a few days to a week.
Understanding What Comes Next
A biopsy result shapes every decision that follows it. Bringing prior PSA history and any existing MRI reports to the first consultation is the most direct way to understand whether MR fusion biopsy is the appropriate next step.
Frequently Asked Questions
Most patients describe the procedure as uncomfortable rather than significantly painful, particularly with local anesthesia or sedation used during the biopsy.
No, a raised PSA can also result from an enlarged prostate, inflammation, or infection. The biopsy helps determine the specific cause.
Results are typically available within about a week, and the findings are reviewed together to determine the next steps.
If cancer is found, the biopsy results, including the grade and extent of disease, help determine whether surgery, radiation, active surveillance, or another approach is most appropriate.
Compared to a standard biopsy that samples the prostate more broadly, MR fusion biopsy targets the specific area identified on MRI, which can improve the likelihood of detecting clinically significant cancer in that area.